Mitsuyo Kondo

460 total citations
13 papers, 388 citations indexed

About

Mitsuyo Kondo is a scholar working on Molecular Biology, Surgery and Organic Chemistry. According to data from OpenAlex, Mitsuyo Kondo has authored 13 papers receiving a total of 388 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Surgery and 4 papers in Organic Chemistry. Recurrent topics in Mitsuyo Kondo's work include Gastroesophageal reflux and treatments (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Renin-Angiotensin System Studies (3 papers). Mitsuyo Kondo is often cited by papers focused on Gastroesophageal reflux and treatments (4 papers), Helicobacter pylori-related gastroenterology studies (4 papers) and Renin-Angiotensin System Studies (3 papers). Mitsuyo Kondo collaborates with scholars based in Japan, United States and Canada. Mitsuyo Kondo's co-authors include Naoki Tarui, Nobuhiro Inatomi, Atsushi Hasuoka, Masahiro Kajino, Keizo Hirase, Osamu Kurasawa, Yasuyoshi Arikawa, Haruyuki Nishida, Terufumi Takagi and Akio Imanishi and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Medicinal Chemistry and Bioorganic & Medicinal Chemistry.

In The Last Decade

Mitsuyo Kondo

13 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsuyo Kondo Japan 9 166 125 89 88 57 13 388
Yasuyoshi Arikawa Japan 12 204 1.2× 448 3.6× 219 2.5× 200 2.3× 95 1.7× 23 843
Kazuyoshi Tomita Japan 10 158 1.0× 80 0.6× 92 1.0× 32 0.4× 15 0.3× 19 379
Carlos Rodríguez Ulloa Mexico 4 63 0.4× 47 0.4× 108 1.2× 31 0.4× 38 0.7× 16 331
Christopher L. Heran United States 14 121 0.7× 48 0.4× 46 0.5× 12 0.1× 37 0.6× 22 503
Teruki Hamada Japan 9 126 0.8× 97 0.8× 76 0.9× 55 0.6× 24 0.4× 18 318
Akifumi Kogame Japan 9 186 1.1× 24 0.2× 127 1.4× 27 0.3× 21 0.4× 14 380
Joseph A. Tino United States 13 169 1.0× 172 1.4× 25 0.3× 33 0.4× 4 0.1× 27 469
Pia Lorentzon Sweden 11 328 2.0× 31 0.2× 196 2.2× 165 1.9× 63 1.1× 16 614
Marie Besancon United States 14 442 2.7× 48 0.4× 394 4.4× 331 3.8× 89 1.6× 17 810
Eman A. Ahmed Egypt 10 37 0.2× 228 1.8× 59 0.7× 11 0.1× 11 0.2× 34 385

Countries citing papers authored by Mitsuyo Kondo

Since Specialization
Citations

This map shows the geographic impact of Mitsuyo Kondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuyo Kondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuyo Kondo more than expected).

Fields of papers citing papers by Mitsuyo Kondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuyo Kondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuyo Kondo. The network helps show where Mitsuyo Kondo may publish in the future.

Co-authorship network of co-authors of Mitsuyo Kondo

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuyo Kondo. A scholar is included among the top collaborators of Mitsuyo Kondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuyo Kondo. Mitsuyo Kondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sasaki, Yusuke, Matthew Reynolds, Nozomu Sakai, et al.. (2023). Discovery of a Novel Series of Potent, Selective, Orally Available, and Brain-Penetrable C1s Inhibitors for Modulation of the Complement Pathway. Journal of Medicinal Chemistry. 66(9). 6354–6371. 7 indexed citations
2.
Imaeda, Yasuhiro, Yoshiyuki Fukase, Koichi Iwanaga, et al.. (2018). Discovery of benzimidazole derivatives as orally active renin inhibitors: Optimization of 3,5-disubstituted piperidine to improve pharmacokinetic profile. Bioorganic & Medicinal Chemistry. 26(12). 3261–3286. 6 indexed citations
3.
Ito, Masahiro, Toshio Tanaka, Noriko Uchiyama, et al.. (2018). Discovery of 3-Benzyl-1-(trans-4-((5-cyanopyridin-2-yl)amino)cyclohexyl)-1-arylurea Derivatives as Novel and Selective Cyclin-Dependent Kinase 12 (CDK12) Inhibitors. Journal of Medicinal Chemistry. 61(17). 7710–7728. 51 indexed citations
4.
Kondo, Mitsuyo, Shin-ichi Matsumoto, Daisuke Morishita, et al.. (2017). High-Throughput Screening to Identify Inhibitors of DEAD Box Helicase DDX41. SLAS DISCOVERY. 22(9). 1084–1092. 18 indexed citations
5.
Imaeda, Toshihiro, Koji Ono, Kazuo Nakai, et al.. (2017). Discovery, synthesis, and structure-activity relations of 3,4-dihydro-1H-spiro(naphthalene-2,2′-piperidin)-1-ones as potassium-competitive acid blockers. Bioorganic & Medicinal Chemistry. 25(14). 3719–3735. 10 indexed citations
6.
Imaeda, Yasuhiro, Michiko Tawada, Mitsuyo Kondo, et al.. (2016). Structure-based design of a new series of N-(piperidin-3-yl)pyrimidine-5-carboxamides as renin inhibitors. Bioorganic & Medicinal Chemistry. 24(22). 5771–5780. 11 indexed citations
7.
Imaeda, Yasuhiro, Yoshiyuki Fukase, Keiji Kusumoto, et al.. (2016). Discovery of TAK-272: A Novel, Potent, and Orally Active Renin Inhibitor. ACS Medicinal Chemistry Letters. 7(10). 933–938. 22 indexed citations
8.
Tawada, Michiko, Yasuhiro Imaeda, Hideyuki Oki, et al.. (2016). Novel approach of fragment-based lead discovery applied to renin inhibitors. Bioorganic & Medicinal Chemistry. 24(22). 6066–6074. 6 indexed citations
9.
Kunitomo, Jun, Masato Yoshikawa, Makoto Fushimi, et al.. (2014). Discovery of 1-[2-Fluoro-4-(1H-pyrazol-1-yl)phenyl]-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one (TAK-063), a Highly Potent, Selective, and Orally Active Phosphodiesterase 10A (PDE10A) Inhibitor. Journal of Medicinal Chemistry. 57(22). 9627–9643. 56 indexed citations
10.
Nishida, Haruyuki, Atsushi Hasuoka, Yasuyoshi Arikawa, et al.. (2012). Discovery, synthesis, and biological evaluation of novel pyrrole derivatives as highly selective potassium-competitive acid blockers. Bioorganic & Medicinal Chemistry. 20(12). 3925–3938. 42 indexed citations
11.
Arikawa, Yasuyoshi, Haruyuki Nishida, Osamu Kurasawa, et al.. (2012). Discovery of a Novel Pyrrole Derivative 1-[5-(2-Fluorophenyl)-1-(pyridin-3-ylsulfonyl)-1H-pyrrol-3-yl]-N-methylmethanamine Fumarate (TAK-438) as a Potassium-Competitive Acid Blocker (P-CAB). Journal of Medicinal Chemistry. 55(9). 4446–4456. 128 indexed citations
12.
Kondo, Mitsuyo, et al.. (2011). High-Throughput Screening of Potassium-Competitive Acid Blockers. SLAS DISCOVERY. 17(2). 177–182. 24 indexed citations
13.
Itoh, Takashi, Mitsuyo Kondo, Yoko Tanaka, et al.. (2001). Novel Betacellulin Derivatives. Journal of Biological Chemistry. 276(44). 40698–40703. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026